Dr. Reddy's Laboratories Ltd ADR (RDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RDY | BBIO | SUPN | ||
| Company | Dr. Reddy's Laboratories Ltd ADR | Bridgebio Pharma Inc | Supernus Pharm | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 13.71 | 69.22 | 48.86 | ||
| High | 13.86 | 71.27 | 49.36 | ||
| Low | 13.60 | 68.40 | 47.75 | ||
| Latest | 13.69 | 69.60 | 49.25 | ||
| Change | -0.07 | +1.06 | +1.49 | ||
| % Change | -0.51% | +1.55% | +3.12% | ||
| Volume | 3,769,924 | 1,422,945 | 831,152 | ||
| 20-Day Average Volume | 2,243,281 | 2,476,802 | 901,263 | ||
| Previous Close | 13.76 | 68.54 | 47.76 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 14.28 | 68.30 | 52.55 | ||
| 20-Day Raw Stochastic | 7.50% | 52.00% | 18.83% | ||
| 20-Day Relative Strength | 42.17 | 48.63 | 44.29 | ||
| Weighted Alpha | +0.39 | +85.97 | +45.60 | ||
| Today's Opinion | 40% Sell | 24% Buy | 40% Buy | ||
| Previous Opinion | 40% Sell | 24% Buy | 24% Buy | ||
| Last Month's Opinion | 24% Buy | 24% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.56% since 03/16/26 | -2.01% since 03/16/26 | -1.91% since 03/16/26 | ||
| Low | 13.60 on 03/23/26 | 68.00 on 03/20/26 | 46.83 on 03/20/26 | ||
| High | 14.31 on 03/19/26 | 72.35 on 03/20/26 | 51.15 on 03/17/26 | ||
| 1-Month | |||||
| %Chg | -6.87% since 02/23/26 | +2.49% since 02/23/26 | -2.84% since 02/23/26 | ||
| Low | 13.60 on 03/23/26 | 62.77 on 03/03/26 | 46.83 on 03/20/26 | ||
| High | 14.80 on 02/25/26 | 75.90 on 03/10/26 | 59.68 on 02/25/26 | ||
| 3-Month | |||||
| %Chg | -3.79% since 12/23/25 | -8.90% since 12/23/25 | -4.76% since 12/23/25 | ||
| Low | 12.81 on 01/20/26 | 62.77 on 03/03/26 | 46.83 on 03/20/26 | ||
| High | 14.80 on 02/25/26 | 84.94 on 02/12/26 | 59.68 on 02/25/26 | ||
| 6-Month | |||||
| %Chg | -5.65% since 09/23/25 | +35.15% since 09/23/25 | +5.17% since 09/23/25 | ||
| Low | 12.81 on 01/20/26 | 48.78 on 09/25/25 | 43.11 on 11/05/25 | ||
| High | 14.95 on 10/22/25 | 84.94 on 02/12/26 | 59.68 on 02/25/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,484,564 | 13,287,371 | 2,750,116 | ||
| Shares Outstanding, K | 834,634 | 193,863 | 57,582 | ||
| Annual Sales | 3,811,000,000 | 502,080,000 | 718,950,000 | ||
| Annual Net Income | 663,000,000 | -724,930,000 | -38,550,000 | ||
| Last Quarter Sales | 977,400,000 | 154,180,000 | 211,570,000 | ||
| Last Quarter Net Income | 135,500,000 | -192,860,000 | -4,110,000 | ||
| 60-Month Beta | 0.34 | 1.13 | 0.70 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.16 on 01/21/26 | -1.00 on 02/24/26 | 0.92 on 02/24/26 | ||
| Latest Earnings Date | 05/08/26 | 05/05/26 | 05/05/26 | ||
| Most Recent Dividend | 0.071 on 07/25/25 | N/A | N/A | ||
| Next Ex-Dividends Date | 07/25/25 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 18.36 | 0.00 | 21.52 | ||